AQP4-IgG is highly useful for differentiating NMOSD from other inflammatory diseases of the CNS, such as multiple sclerosis (MS) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) [1,4,5]. This evidence concerns the gene AQP4 and myeloid sarcoma.